Paul W. Abramowitz, Pharm.D., FASHP, Named ASHP Executive Vice President and CEO-Designate

by American Society of Health-System Pharmacists
April 22, 2011

Source: American Society of Health-System Pharmacists

BETHESDA, MD, April 22, 2011 -The Board of Directors of the American Society of Health-System Pharmacists (ASHP) has selected Paul W. Abramowitz, Pharm.D., FASHP, as the executive vice president and CEO-designate. Abramowitz will succeed Henri R. Manasse, Jr., Ph.D., Sc.D., who will retire in December.

Abramowitz is currently the associate hospital director for professional services and chief pharmacy officer at the University of Iowa Hospitals and Clinics, Iowa City. He also holds appointments as assistant dean and professor at the University of Iowa College of Pharmacy. Abramowitz received his doctor of pharmacy degree from the University of Michigan and Bachelor of Science degree in pharmacy from the University of Toledo. He completed his residency training at the University of Michigan Hospitals and Clinics, Ann Arbor.
Abramowitz has had a distinguished career of leadership, having held director of pharmacy and faculty positions at the University of Minnesota, Minneapolis, and Virginia Commonwealth University, Richmond. In addition to his contributions to pharmacy practice, he has served the profession in several capacities, including chair of the Iowa Board of Pharmacy and chair of the Board of the Iowa Statewide Poison Control Center. Abramowitz served as president of ASHP from 1993 to 1994 and as treasurer of ASHP and the ASHP Research and Education Foundation from 2007 to 2010. He has received many honors, including the Harvey A. K. Whitney Lecture Award in 2009, health-system pharmacy’s highest honor.
“After a thorough and exhaustive search process, I am excited to welcome Paul Abramowitz back to the ASHP family, and I look forward to working with him to advance the practice of pharmacists in hospitals and health systems,” said ASHP President Diane B. Ginsburg, M.S., R.Ph., FASHP.  “The ASHP Board of Directors has complete confidence that Dr. Abramowitz is extremely well equipped to lead this vibrant and strong organization into the future. Dr. Abramowitz knows ASHP and pharmacy practice, and he has the insight and vision to take this organization to the next level.”
Ginsburg added, “I would also like to recognize and thank Dr. Henri R. Manasse, Jr., for his exceptional leadership that has brought the Society the high level of respect, strength, and organizational effectiveness that it appreciates today,” noted Ginsburg.
Abramowitz will join ASHP as executive vice president and CEO-designate in September, assuming full responsibility on January 1, 2012. “I am so pleased to have the opportunity to take the reins of such an effective organization, and I would like to thank President Ginsburg and the Board of Directors for granting me this wonderful opportunity,” said Abramowitz. “I am looking forward to working with Dr. Manasse, the Board, and staff on this well-planned transition beginning on September 1, 2011, and to hitting the ground running in January.”
Manasse will continue as ASHP’s executive vice president and chief executive officer through December 31, 2011, and will serve as an outside consultant to ASHP through June 2012.

For more than 60 years, ASHP has helped pharmacists who practice in hospitals and health systems improve medication use and enhance patient safety. The Society's 35,000 members include pharmacists and pharmacy technicians who practice in inpatient, outpatient, home-care, and long-term-care settings, as well as pharmacy students. For more information about the wide array of ASHP activities and the many ways in which pharmacists help people make the best use of medicines, visit ASHP's Web site,, or its consumer Web site,

News » Public News »